Blonder Tongue Laboratories, Inc.
BDRL
$0.13
-$0.019-12.75%
| 12/31/2022 | 09/30/2022 | 06/30/2022 | 03/31/2022 | 12/31/2021 | |
|---|---|---|---|---|---|
| Net Income | -3,576.19% | -180.81% | -14.96% | 88.71% | 101.12% |
| Total Depreciation and Amortization | -21.91% | -10.12% | -3.49% | 0.72% | 3.63% |
| Total Amortization of Deferred Charges | -26.79% | -21.43% | -12.32% | 46.46% | 180.00% |
| Total Other Non-Cash Items | 227.55% | 217.02% | 193.13% | -213.11% | -216.28% |
| Change in Net Operating Assets | 63.11% | 90.07% | -177.73% | -153.80% | -171.45% |
| Cash from Operations | -18.42% | -26.15% | -152.13% | 38.06% | 63.67% |
| Capital Expenditure | -54.84% | -38.46% | 6.98% | 79.25% | 81.21% |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | 87.27% | 87.50% | 88.52% | 66.13% | -111.54% |
| Cash from Investing | 36.05% | 35.79% | 54.81% | 75.57% | 54.97% |
| Total Debt Issued | 108.06% | 210.43% | 153.29% | -91.51% | -64.22% |
| Total Debt Repaid | -1,121.31% | -344.27% | 182.62% | 141.09% | 89.73% |
| Issuance of Common Stock | -- | -79.48% | -41.26% | -32.45% | -31.64% |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | -14.81% | 5.45% | 162.40% | -38.69% | -49.72% |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -195.12% | -153.06% | 114.05% | 334.78% | 140.76% |
